Cheryl Laboratories Pvt Ltd, a active private limited company, was established on 16 January 1987 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1987PTC042262. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.50 Cr.
It upholds a compliant status. Its leadership includes Kanav Chandresh Thakker (Director), Jay Mukund Thakker (Director), Dinesh Vallabhdas Thakker (Director). It holds ₹73.42 Cr open charges and ₹21.36 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Persian Ap Plot No 434 Groundflooe V P Road Andhari West, Mumbai, Maharashtra, 400058.
U24230MH1987PTC042262
042262
16 January 1987
₹1.50 Cr
₹1.50 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Cheryl Laboratories Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kanav Chandresh Thakker | Director | 29 Sep 2018 | Current |
| Jay Mukund Thakker | Director | 01 Feb 2010 | Current |
| Dinesh Vallabhdas Thakker | Director | 31 Mar 2001 | Current |
| Mukund Vallabhdas Thakker | Director | 31 Mar 2001 | Current |
| Chandresh Vallabhdas Thakker | Director | 31 Mar 2001 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cheryl Laboratories Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 16.21% increase. The company also saw a substantial improvement in profitability, with a 22.03% increase in profit. The company's net worth Soared by an impressive increase of 24.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cheryl Laboratories had a promoter holding of 94.45% and a public holding of 5.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹734,215,200.00
₹213,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Citi Bank N.A. | ₹7.50 Cr | Open |
| 22 Sep 2022 | Hdfc Bank Limited | ₹2.44 M | Open |
| 22 Sep 2022 | Hdfc Bank Limited | ₹2.44 M | Open |
| 22 Sep 2022 | Hdfc Bank Limited | ₹2.44 M | Open |
| 01 Sep 2022 | Hdfc Bank Limited | ₹1.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cheryl Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cheryl Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cheryl Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Axis Bank Limited of Rs. 2.00 Cr registered on 04 Oct 2001 with Charge ID 90166727 was modified on 03 Jun 2025. was completed.
A charge registered on 31 Oct 2020 via Charge ID 100388604 with Axis Bank Limited was fully satisfied on 27 Feb 2025. was recorded as a recent event.
The activity Cheryl Laboratories Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge registered on 18 Dec 2001 via Charge ID 90237468 with Uti Bank Ltd. was fully satisfied on 28 Aug 2024. was documented.
Cheryl Laboratories Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Citi Bank N.A. amounted to Rs. 7.50 Cr with Charge ID 100901186 was registered on 26 Mar 2024. was documented.
The CIN of Cheryl Laboratories Pvt Ltd is U24230MH1987PTC042262.
Cheryl Laboratories Pvt Ltd is headquartered at Persian Ap Plot No 434 Groundflooe V P Road Andhari West, Mumbai, Maharashtra, 400058.
Cheryl Laboratories Pvt Ltd was incorporated on 16 January 1987.
The current directors of Cheryl Laboratories Pvt Ltd are
The primary industry of Cheryl Laboratories Pvt Ltd is Manufacturing.
Cheryl Laboratories Pvt Ltd is unlisted.
The authorized capital of Cheryl Laboratories Pvt Ltd is ₹1.50 Cr, and the paid-up capital is ₹1.50 Cr.
The compliance status of Cheryl Laboratories Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX